A Randomized, Open-label, Single-dose Phase 1 Clinical Trial to Compare the Effect of Timing of Food on the Pharmacokinetics and Pharmacodynamics of K-CAB (Tegoprazan) in Healthy Male Subjects
Latest Information Update: 16 Jul 2020
At a glance
- Drugs Tegoprazan (Primary)
- Indications Erosive oesophagitis; Gastric ulcer; Gastro-oesophageal reflux
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors HK inno.N
Most Recent Events
- 20 Aug 2019 Status changed from recruiting to completed.
- 02 Apr 2019 Status changed from not yet recruiting to recruiting.
- 08 Mar 2019 Helicobacter pylori negative subjects are included so Helicobacter pylori infection is not added in indications. Kindly update further.